Bio Essence Corp. is a herbal health, diet, and nutrition company. The Company is mainly engaged in selling health supplements and providing original equipment manufacturing (OEM) services. The Company also outsources manufacturing / OEM services.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
30/10/26	$0.4700	+6.82%	1,000
29/10/26	$0.4400	+4.74%	3,500

Real-time OTC Markets

More quotes

Market Closed - OTC Markets 20:00:15 15/05/2026 +03			5-day change	1st Jan Change
0.3800 ^USD	-.--%		-9.55%	+533.33%

10-23	Bio Essence Corp. Announces Board Changes, Effective October 19, 2026	CI
08-14	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Market Cap	25.29M 22.65M 20.83M 18.88M 35.29M 2.4B 35.95M 248M 99.74M 1.26B 94.91M 92.89M 3.98B	P/E 2024	-7x	P/E 2025	2.54x
Enterprise Value	26.85M 24.05M 22.12M 20.04M 37.47M 2.55B 38.17M 264M 106M 1.34B 101M 98.63M 4.23B	EV / Sales 2024	36.6x	EV / Sales 2025	2.03x
Free-Float	36.08%	Yield 2024 *	-	Yield 2025	-

10-23	Bio Essence Corp. Announces Board Changes, Effective October 19, 2026	CI
08-14	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-19	Bio Essence Corporation completed the acquisition of MediFlow AI from Zhituo Software Co., Limited.	CI
05-15	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-25	Bio Essence Corporation has entered into a Asset Purchase Agreement to acquire MediFlow AI from Zhituo Software Co., Limited for $3.1 million.	CI
03-27	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-27	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
11-12	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/05/25	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
28/03/25	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/03/25	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
14/11/24	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

11-12	Bio Essence : Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q)	PU
07/10/24	Bio Essence : Amendment to Quarterly Report Form 10 Q/A	PU
07/10/24	Bio Essence : Non Reliance of Financial Report Form 8 K	PU
30/03/23	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operation. (form 10-K)	AQ
16/05/22	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ

Bio Essence Corporation Stock

Stocks

BIOE

US09090C1053

Pharmaceuticals

Valuation: Bio Essence Corporation

Chart: Bio Essence Corporation

Latest news: Bio Essence Corporation

Press Releases: Bio Essence Corporation

Quotes and Performance

Price Extremes

Managers and Directors: Bio Essence Corporation

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

1 week	-9.55%
Current month	-19.15%
1 month	+108.91%
3 months	+40.58%
6 months	-24.00%
Current year	+533.33%

1 week	0.38	0.47
1 month	0.19	0.47
Current year	0.05	0.52
1 year	0.05	0.52
3 years	0.05	10.81
5 years	0.05	10.81
10 years	0.05	10.81

Manager	Title	Age	Since
Yin Yan CEO	Chief Executive Officer	50	-
Bill Sluss DFI	Director of Finance/CFO	71	07/09/2023
Tuan Tran COO	Chief Operating Officer	52	01/01/2018

Director	Title	Age	Since
Bill Sluss BRD	Director/Board Member	71	18/06/2024
Yin Yan CHM	Chairman	50	-
Siyavash Fooladian BRD	Director/Board Member	54	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
10/28/24 A	Yin Yan	Sell	Chief Executive Officer	323,845	0.8520%
7/11/24 A	Yin Yan	Sell	Chief Executive Officer	92,190	0.2425%
7/2/24 A	Yin Yan	Sell	Chief Executive Officer	223,965	0.5892%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIO ESSENCE CORPORATION	-.--%	-9.55%	+435.21%	-25.49%	25.29M
ELI LILLY AND COMPANY	+3.19%	+11.31%	+64.28%	+155.91%	1,263B
JOHNSON & JOHNSON	-0.73%	+3.56%	+44.65%	+84.17%	658B
ABBVIE INC.	+1.41%	+3.24%	+35.25%	+108.88%	521B
ROCHE HOLDING AG	+0.42%	+3.20%	+55.81%	+72.50%	391B
MERCK & CO., INC.	+2.18%	+2.93%	+73.90%	+45.59%	369B
NOVARTIS AG	+1.12%	+4.52%	+34.76%	+58.24%	307B
ASTRAZENECA PLC	+6.96%	+8.86%	+11.95%	+36.20%	290B
AMGEN INC.	+1.15%	+6.09%	+56.15%	+82.25%	252B
GILEAD SCIENCES, INC.	+3.06%	+9.38%	+42.48%	+117.32%	212B
Average	+1.88%	+5.31%	+85.45%	+73.56%	426.2B
Weighted average by Cap.	+2.01%	+6.60%	+50.51%	+100.44%

	2024	2025
Net sales	324K 290K 267K 242K 452K 30.76M 460K 3.18M 1.28M 16.18M 1.22M 1.19M 51.03M	1.9M 1.7M 1.56M 1.42M 2.65M 180M 2.7M 18.64M 7.48M 94.78M 7.12M 6.97M 299M
Net income	-1.31M -1.17M -1.08M -977K -1.83M -124M -1.86M -12.86M -5.16M -65.37M -4.91M -4.81M -206M	896K 803K 738K 669K 1.25M 85.09M 1.27M 8.8M 3.53M 44.76M 3.36M 3.29M 141M
Net Debt	2.7M 2.42M 2.23M 2.02M 3.77M 257M 3.84M 26.56M 10.66M 135M 10.15M 9.93M 426M	1.56M 1.4M 1.29M 1.17M 2.18M 148M 2.22M 15.36M 6.16M 78.07M 5.87M 5.74M 246M